(Q33903877)

English

The taxanes: an update

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

The taxanes: an update (English)

1 reference

Europe PubMed Central

29 July 2017

author name string

J Crown

1

1 reference

Europe PubMed Central

29 July 2017

M O'Leary

2

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

355

1 reference

Europe PubMed Central

29 July 2017

1176-1178

1 reference

Europe PubMed Central

29 July 2017

9210

1 reference

Europe PubMed Central

29 July 2017

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of 3-hour versus 24-hour infusion of high-dose paclitaxel in patients with metastatic or locally advanced breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-26

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902074-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(00)02074-2

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33903877&oldid=1629468682"